Does Rallies show 13F holders for KALA?

Yes. Rallies tracks hedge fund and 13F ownership data for KALA, including fund names, share counts, latest tracked quarter, and position changes when available.

Is KALA research on Rallies investment advice?

No. Rallies provides research, data, and educational context for KALA. It does not provide personalized investment advice.

KALA (KALA BIO, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings

KALA BIO, Inc. Common Stock (KALA) is a publicly traded Healthcare sector company. As of May 21, 2026, KALA trades at $2.66 with a market cap of $50.38M and a P/E ratio of -0.82. KALA moved +4.35% today. Year to date, KALA is -91.40%; over the trailing twelve months it is -98.66%. Its 52-week range spans $2.52 to $1,030.00. Rallies surfaces KALA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns KALA stock?

Hedge funds tracked by Rallies that own KALA include Renaissance Technologies and Two Sigma. The latest tracked quarter is Sep 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for KALA BIO, Inc. Common Stock.

KALA Key Metrics

Key financial metrics for KALA
Metric	Value
Price	$2.66
Market Cap	$50.38M
P/E Ratio	-0.82
EPS	$-3.31
Dividend Yield	0.00%
52-Week High	$1,030.00
52-Week Low	$2.52
Volume	86.39K
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-26.98M
Gross Margin	0.00%

Top Hedge Funds Holding KALA

Renaissance Technologies holds 21.47K shares of KALA, changed +88.36% as of Sep 30, 2024.
Two Sigma holds 11.88K shares of KALA, changed -15.19% as of Dec 31, 2024.

Latest KALA News

Kala Bio Initiates 1-for-50 Reverse Split, Reduces Shares Outstanding to 18.6M — May 7, 2026
Trump Executive Order Allocates $50M to Psychedelic Research Boosting Kala Bio’s AI Platform — Apr 21, 2026
Kala Bio Deploys Bionic Intelligence Agent for Biotech with 70B-Parameter AI Model — Mar 30, 2026
Kala Bio to Ship First AI Agent in 14 Days, Tackles $180B Healthcare AI Market — Mar 11, 2026
KALA BIO Secures Exclusive License to Younet AI's Researgency Platform — Mar 9, 2026

Recent KALA Insider Trades

Iwicki Mark T sold 154.89K (~$125.46K) on Oct 23, 2025.
Reumuth Mary sold 967 (~$792.94) on Oct 23, 2025.
Reumuth Mary sold 32.23K (~$26.75K) on Oct 22, 2025.

KALA Analyst Consensus

KALA analyst coverage data. Average price target: $0.00.

Common questions about KALA

Who owns KALA stock?: Hedge funds tracked by Rallies that own KALA include Renaissance Technologies and Two Sigma. The latest tracked quarter is Sep 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for KALA BIO, Inc. Common Stock.
Does Rallies show 13F holders for KALA?: Yes. Rallies tracks hedge fund and 13F ownership data for KALA, including fund names, share counts, latest tracked quarter, and position changes when available.
Is KALA research on Rallies investment advice?: No. Rallies provides research, data, and educational context for KALA. It does not provide personalized investment advice.